Terms: = Ovarian cancer AND PRCC, Q92733, TPRC, RCCP1, MGC4723, MGC17178, ENSG00000143294, 5546
4 results:
1. Evaluation of Human Kidney Injury Molecule 1 (hKIM-1) Expression in Tumors From Various Organs by Messenger RNA In Situ Hybridization.
Sarami I; Shi J; Lin B; Liu H; Monroe R; Lin F
Am J Clin Pathol; 2021 Jul; 156(2):288-299. PubMed ID: 33608720
[TBL] [Abstract] [Full Text] [Related]
2. Onconeuronal antigen Cdr2 correlates with HIF prolyl-4-hydroxylase PHD1 and worse prognosis in renal cell carcinoma.
Kaufmann MR; Schraml P; Hermanns T; Wenger RH; Camenisch G
Exp Mol Pathol; 2013 Jun; 94(3):453-7. PubMed ID: 23531419
[TBL] [Abstract] [Full Text] [Related]
3. The utility of PAX-2 and renal cell carcinoma marker immunohistochemistry in distinguishing papillary renal cell carcinoma from nonrenal cell neoplasms with papillary features.
Sharma SG; Gokden M; McKenney JK; Phan DC; Cox RM; Kelly T; Gokden N
Appl Immunohistochem Mol Morphol; 2010 Dec; 18(6):494-8. PubMed ID: 21102195
[TBL] [Abstract] [Full Text] [Related]
4. Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.
Simon-Kayser B; Scoul C; Renaudin K; Jezequel P; Bouchot O; Rigaud J; Bezieau S
Genes Chromosomes Cancer; 2005 May; 43(1):83-94. PubMed ID: 15723337
[TBL] [Abstract] [Full Text] [Related]
